Laparoscopic sleeve gastrectomy (LSG) is one of the most popular bariatric procedure. One anastomosis gastric bypass (OAGB) is rapidly emerging as a safe and effective metabolic procedure. This study aims at comparing the 1-year follow-up results of OAGB and LSG in terms of excess weight loss, complications, resolution of comorbidities, and quality of life.
A prospective randomized study of results between 100 LSG and 101 OAGB patients was done from 2012 to 2015. The results were compared regarding operative outcomes, percentage of excess weight loss, complications, resolution of comorbidities, and quality of life (BAROS score).
The mean BMI for the OAGB and LSG group was 44.31 and 43.75 kg/m2, respectively. Percentage of excess weight loss (%EWL) for OAGB vs LSG was 66.87 ± 10.87 vs 63.97 ± 13.24 at 1 year (p > 0.05), respectively. Diabetes remission was 83.63 % in OAGB patients and 76.58 % in LSG patients. Remission of hypertension is 64.15 % in OAGB patients and 66.07 % in LSG patients. Bariatric Analysis Reporting and Outcome System (BAROS) was 3.71 in LSG and 3.96 in OAGB.
In our study, there was no significant difference between LSG and OAGB in outcome at 1 year follow-up in % excess weight loss, remission of HTN, and quality of life. OAGB has marginally better outcome in T2 DM remission. However, a longer follow-up is required to establish a correct comparative result.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Sundbom M. Laparoscopic revolution in bariatric surgery. World J Gastroenterol. 2014;20(41):15135–43.
Lee WJ, Ser KH, Lee YC, et al. Laparoscopic roux-en-Y vs. minigastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22:1827–34.
Noun R, Skaff J, Riachi E, et al. One thousand consecutive minigastric bypass: short and long term outcome. Obes Surg. 2012;22:697–703.
Musella M, Sousa A, Greco F, et al. The laparoscopic mini-gastric bypass: the Italian experience: outcomes from 974 consecutive cases in a multi-center review. Surg Endosc. 2014;28:156–63.
Kular KS, Manchanda N, Rutledge R. A 6-year experience with 1,054 mini-gastric bypasses—first study from Indian subcontinent. Obes Surg. 2014;24:1430–5.
Baltasar A, Serra C, Perez N, et al. Laparoscopic sleeve gastrectomy: a multi-purpose bariatric operation. Obes Surg. 2005;15(8):1124–8.
Eid GM, Brethauer S, Mattar SG, et al. Laparoscopic sleeve gastrectomy for super obese patients: forty-eight percent excess weight loss after 6 to 8 years with 93 % follow-up. Ann Surg. 2012;256(2):262–5.
Sanchez-Santos R, Masdevall C, Baltasar A, et al. Short- and midterm outcomes of sleeve gastrectomy for morbid obesity: the experience of the Spanish National Registry. Obes Surg. 2009;19(9):1203–10.
Rutledge R. The mini-gastric bypass: experience with the 1,274 cases. Obes Surg. 2001;11:276–80.
Mahawar KK, Jennings N, Rown J, et al. “mini” gastric bypass: systematic review of a controversial procedure. Obesity Surg. 2013;23(11):1890–8.
Wang HH, Wei PL, Lee YC, et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15:648–54.
Noun R, Zeidan S. Laparoscopic mini-gastric bypass: an effective option for the treatment of morbid obesity. J Chir (Paris). 2007;144:301–4.
Quan Y, Huang A, Ye M, et al. Efficacy of laparoscopic mini gastric bypass for obesity and type 2 diabetes mellitus: a systematic review and meta-analysis. Gastroenterol Res Pract. 2015:152852.
Kim Z, Hur KY. Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. World J Surg. 2011;35:631–6.
Lee WJ, Wang W, Lee YC, et al. Effects of laparoscopic minigastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and <35 kg/m2. J Gastrointest Surg. 2008;12:945–52.
Horatio E. Oria, Melodie K. Moorehead. Bariatric analysis and reporting outcome system (BAROS. Obes Surg. 1998;8:487–99.
Lakdawala M, Bhasker A, Report: Asian Consensus Meeting on Metabolic Surgery. Recommendations for the use of Bariatric and Gastrointestinal Metabolic Surgery for Treatment of Obesity and Type II Diabetes Mellitus in the Asian Population Obesity Surgery. 2010;20(7):929–936
Lee W-J, Chong K, Chen J-C, et al. Predictors of diabetes remission after bariatric surgery in Asia. Asian Journal of Surgery. 2012;35:67e73.
Li J, Lai D, Wu D. Laparoscopic roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy to treat morbid obesity-related comorbidities: a systematic review and meta-analysis. Obes Surg. 2016;26:429–42.
Boza C, Gamboa C, Salinas J, et al. Laparoscopic roux–en–Y gastric bypass vs laparoscopic sleeve gastrectomy: a case control study and 3 years of follow up. Surg Obes Relat Dis. 2012;8:243–9.
Kular KS, Manchanda N, Rutledge R. Analysis of the five-year outcomes of sleeve gastrectomy and mini gastric bypass: a report from the Indian sub-continent. Obes Surg. 2014;24:1724–8.
Jammu GS, Sharma R. A 7-year clinical audit of 1107 cases comparing sleeve gastrectomy, roux-en-y gastric bypass and mini-gastric bypass, to determine an effective and safe bariatric and metabolic procedure. Obes Surg. doi:10.1007/s11695-015-1869-2.
Yehoshua RT, Eidelman LA, Stein M, et al. Laparoscopic sleeve gastrectomy—volume and pressure assessment. Obes Surg. 2008;18:1083–8.
Tolone S, Cristiana S, Savarino E, et al. Effects of omega-loop bypass on esophagogastric junction function. Surg Obes Relat Dis. 2015. doi:10.1016/j.soard.2015.03.011.
Sacks BC, Mattar SG, Qureshi FG, et al. Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2(1):11–6.
Gumbs AA, Duffy AJ, Bell RL. Incidence and management of marginal ulceration after laparoscopic roux-Y gastric bypass. Surg Obes Relat Dis. 2006;2(4):460–3.
Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis. 2006;2(4):455–9.
Noun R, Skaff J, Riachi E, et al. One thousand consecutive minigastric bypass: short- and long-term outcome. Obes Surg. 2012;22(5):697–703.
Gagner M, Deitel M, Erickson AL, et al. Survey on laparoscopic sleeve Gastrectomy (LSG) at the Fourth International Consensus Summit on Sleeve Gastrectomy. Obes Surg. 2013.
Musella M, Apers J, Rheinwalt K, et al. Efficacy of bariatric surgery in type 2 diabetes mellitus remission: the role of mini gastric bypass/one anastomosis gastric bypass and sleeve gastrectomy at 1 Year of follow-up. A European survey. Obes Surg. 2015. doi:10.1007/s11695-015-1865-6.
Lee W-J, Chong K, Lin Y-H, et al. Laparoscopic sleeve gastrectomy versus single anastomosis (mini) gastric bypass for the treatment of type 2 diabetes mellitus: 5-year results of a randomized trial and study of Incretin effect. Obes Surg. 2014;24:1552–62.
Lee WJ, Chong K, Ser KH, et al. Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 2011;146:143–8.
Milone M, Di Minno MND, Leongito M, et al. Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass. World J Gastroenterol. 2013;19(39):6590–7.
Bruzzi M, Rau C, Voron T, et al. Single anastomosis or mini-gastric bypass: long-term results and quality of life after a 5-year follow-up. Surg Obes Relat Dis. 2015;11:321–6.
Navez J, Dardamanis D, Thissen J-P, et al. Laparoscopic roux-en-Y gastric bypass for morbid obesity: comparison of primary versus Revisional bypass by using the BAROS score. Obes Surg. doi:10.1007/s11695-014-1473-x.
Wolf AM, Falcone AR, Kortner B, et al. BAROS: an effective system to evaluate the results of patients after bariatric surgery. Obes Surg. 2000;10(5):445–50.
Suter M, Paroz A, Calmes JM, et al. European experience with laparoscopic roux-en-Y gastric bypass in 466 obese patients. Br J Surg. 2006;93(6):726–32.
Gould JC, Garren MJ, Boll V, et al. Laparoscopic gastric bypass: risks vs. benefits up to two years following surgery in supersuper obese patients. Surgery. 2006;140(4):524–9.
Myers JA, Clifford JC, Sarker S, et al. Quality of life after laparoscopic adjustable gastric banding using the Baros and Moorehead-Ardelt quality of life questionnaire II. JSLS. 2006;10(4):414–20.
We extend our heartfelt gratitude to Dr. Aruna Tantia, Dr. Pramod Sureka, Dr. Ramanuj Mukherjee, Dr. Bimalendu Sen, Dr. Debjit Ghosh, Ram Sundar Bhandari, OT staffs, Shampa Ghosh, Jhuma Chowdhury, Sonam Gupta, and Hanie Gupta who have worked to make this project a success. The staffs of ILS Hospital deserve special mention for the dedicated support.
Conflict of Interest
Dr. Shivakumar S, Dr. Om Tantia, Dr. Ghanshyam Goyal, Dr. Tamonas Chaudhuri, Dr. Shashi Khanna, Dr. Jagat Pal Singh, and Dr. Anmol Ahuja declare that they have no conflict of interest.
Statement of Informed Consent
Informed consent was obtained from all individual participants included in the study.
Statement of Human and Animal Rights
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
About this article
Cite this article
Seetharamaiah, S., Tantia, O., Goyal, G. et al. LSG vs OAGB—1 Year Follow-up Data—a Randomized Control Trial. OBES SURG 27, 948–954 (2017). https://doi.org/10.1007/s11695-016-2403-x
- One anastomosis gastric bypass (OAGB)
- Laparoscopic sleeve gastrectomy (LSG)
- Bariatric Analysis Reporting and Outcome System (BAROS)
- Gastro-esophageal reflux disease (GERD)
- Excess weight loss (EWL)